Growth Stack: GHRP-2 + Ipamorelin + IGF-1 Research Guide
GHRP-2, Ipamorelin, and IGF-1 LR3 in GH axis research: synergistic mechanisms, pulsatile GH stimulation, IGF-1 receptor signalling, and the science behind this research combination.
GHRP-2, Ipamorelin, and IGF-1 LR3 in GH axis research: synergistic mechanisms, pulsatile GH stimulation, IGF-1 receptor signalling, and the science behind this research combination.
IGF-1 LR3 has a 20–30 hour half-life vs 12–15 minutes for native IGF-1. Full breakdown of clinical dose ranges, safety data, and GH-axis research context.
MOD-GRF 1-29 (CJC-1295 no DAC): mechanism, GHRH receptor pharmacology, clinical trial dose ranges, pulsatile GH data and CJC-1295+DAC comparison. Research only.
A research guide to peptide stacking for muscle growth — covering GH secretagogue compound pairings, BPC-157 + TB-500 combinations, and what the preclinical literature shows.
TB-500 (Thymosin Beta-4) in muscle wasting research: AKT/PI3K activation, satellite cell mechanisms, anti-inflammatory pathways, and angiogenesis data from preclinical studies.
GLP-1 receptor agonists in body composition research: semaglutide (STEP 1), tirzepatide (SURMOUNT-1), retatrutide Phase 2 data, AOD-9604 and their mechanisms.
Ipamorelin vs GHRP-2: selectivity, GH pulse magnitude, cortisol/prolactin side effect data from published research and mechanism differences. Research only.
What doses are documented in BPC-157 preclinical research? A guide to 40+ studies: rodent model parameters, reconstitution, stability and lab preparation.
IGF-1 LR3 is a synthetic IGF-1 analogue with 83 amino acids and a 20-hour half-life, studied for satellite cell activation and anabolic signalling in published research. Research overview.
GHRP-6 vs GHRP-2 head-to-head: mechanism differences, GH pulse amplitude data, cortisol profiles, and which compound suits which research model. Full comparison with published data.